Talazoparib
id:
talazoparib-180-15976897
title:
Talazoparib
text:
Talazoparib, sold under the brand name Talzenna, is an anti-cancer medication used for the treatment of breast cancer and prostate cancer. It is an orally available poly ADP ribose polymerase PARP inhibitor marketed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations. Talazoparib is similar to the first in class PARP inhibitor, olaparib. The most common adverse reactions of any grade were fatigue, anemia, nausea, neutropenia, headache, thrombocytopenia, vomiting, a
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Talazoparib
date created:
2016-01-13T05:45:14Z
date modified:
2024-09-05T14:10:25Z
main entity:
{"identifier":"Q25100990","url":"https://www.wikidata.org/entity/Q25100990"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/44/Talazoparib.svg","width":512,"height":390}
fields total:
13
integrity:
16